查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1424969

細胞穿透胜肽市場，按類型、按應用、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Cell Penetrating Peptide Market, By Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 299 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年細胞穿透胜肽市場規模為15.7723億美元，2024年至2032年複合CAGR為10.2%。

細胞穿透胜肽市場-市場動態

製藥和生物技術公司不斷成長的需求推動市場成長

作為活躍的 CPP 研究和開發組織，製藥和生物技術企業以及大學研究機構都參與了這個市場。例如，根據賓州大學醫學院的一篇論文，賓州大學佩雷爾曼醫學院創建的更好的基因編輯方法可能會推動下一代基因和細胞治療。 CRISPR基因編輯方法是基於特殊的細胞穿透胜肽，與目前改變生物基因組的方法相比具有潛在優勢。從而推動預測期內的市場成長。

細胞穿透胜肽市場-關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 10.2% 左右的CAGR成長

根據類型細分，預計合成 CPP 將在 2023 年顯示最大的市場佔有率

從應用細分來看，2023年藥物傳遞是主導類型

根據最終用戶細分，製藥和生物技術公司是 2023 年的領先類型

按地區分類，北美是 2023 年的主要收入來源

細胞穿透胜肽市場-細分分析：

全球細胞穿透胜肽市場根據類型、應用、最終用戶和地區進行細分。

市場依類型分為三類：合成 CPP、蛋白質衍生 CPP 和嵌合 CPP。該市場主要由合成 CPP 主導。某些合成 CPP 經過專門設計，具有多種功能，能夠同時管理各種有效負載或整合治療和診斷功能。

根據應用，市場分為五類：藥物傳遞、基因傳遞、診斷、分子影像和其他。該市場主要由藥物傳輸領域主導。細胞穿透胜肽（CPP）因其在細胞內運輸多種治療劑的卓越能力而在藥物遞送領域引起了廣泛關注。

根據最終用戶，市場分為四類：製藥和生物技術公司、合約研究組織（CRO）、醫院和診所以及其他。該市場主要由製藥和生物技術公司控制。 CPP 用於功能基因組學研究，提供操縱基因表現和研究細胞功能的方法。

細胞穿透胜肽市場-地理洞察

從地理來看，這個市場遍佈北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些區域根據參與商業活動的國家進一步分類。預計該市場的成長將由北美主導，這主要是由於慢性病和傳染病等疾病的盛行率不斷增加。這些疾病的發病率和盛行率不斷上升，推動了對創新治療方法（包括基於 CPP 的藥物傳輸解決方案）的需求。慢性病通常無法治癒且持續存在，影響約 1.33 億美國人，佔全國總人口的 40% 以上。根據國家衛生委員會報告，到 2020 年，這一數字預計將達到 1.57 億，其中 8,100 萬人患有多種疾病。歐洲是市場成長的第二大地區，這主要是由於醫療保健支出的增加。

細胞穿透胜肽市場-競爭格局：

由於了解細胞過程及其在基因治療、癌症和神經科學相關研究中作為細胞內傳遞工具的作用的基礎研究需求不斷增加，細胞穿透胜肽 (CPP) 市場正在顯著成長。奈米技術、基因編輯和其他生物技術領域也在不斷進步，這可能會在市場上引入新的競爭對手或補充技術。 CPPs 由於其促進治療分子細胞內遞送的潛力而在各個領域，特別是藥物遞送領域引起了相當大的關注。因此，在分析細胞穿透胜肽市場時，考慮其應用背景下的競爭分析和需求至關重要。

最近的發展：

2023年7月，美國FDA接受了Revance Therapeutics, Inc.對DAXXIFY的額外生物製品許可申請，​​該藥物旨在治療成人頸部肌張力失調。

目錄

第1章：細胞穿透胜肽市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的細胞穿透胜肽市場片段
    • 按應用分類的細胞穿透胜肽市場片段
    • 最終用戶的細胞穿透胜肽市場片段
    • 按國家/地區分類的細胞穿透胜肽市場片段
    • 按地區分類的細胞穿透胜肽市場片段
  • 競爭洞察

第 3 章：細胞穿透胜肽主要市場趨勢

  • 細胞穿透胜肽市場促進因素
    • 市場促進因素的影響分析
  • 細胞穿透胜肽市場限制
    • 市場限制影響分析
  • 細胞穿透胜肽市場機會
  • 細胞穿透胜肽市場未來趨勢

第 4 章：細胞穿透胜肽產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：細胞穿透胜肽市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：細胞穿透胜肽市場格局

  • 2023 年細胞穿透胜肽市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：細胞穿透胜肽市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 合成CPP
    • 蛋白質衍生的 CPP
    • 嵌合CPP

第 8 章：細胞穿透胜肽市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 藥物輸送
    • 基因傳遞
    • 診斷
    • 分子影像
    • 其他

第 9 章：細胞穿透胜肽市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 製藥和生物技術公司
    • 合約研究組織 (CRO)
    • 醫院和診所
    • 其他

第 10 章：細胞穿透胜肽市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美細胞穿透胜肽主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲細胞穿透胜肽主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區細胞穿透胜肽主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲細胞穿透胜肽主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲細胞穿透胜肽主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：關鍵供應商分析-細胞穿透胜肽產業

  • 競爭儀表板
  • 公司簡介
    • Pepscan
    • Creative Peptides
    • Cupidpeptides
    • AltaBioscience Ltd
    • AnaSpec
    • Peptomyc
    • BioAlps
    • Sarepta Therapeutics, Inc.
    • REVANCE THERAPEUTICS
    • PolyPeptide Group
    • Bachem
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2169

REPORT HIGHLIGHT

Cell Penetrating Peptide Market size was valued at USD 1,577.23 Million in 2023, expanding at a CAGR of 10.2% from 2024 to 2032.

Cell-penetrating peptides (CPPs) are a broad class of short peptides that can penetrate cell membranes without compromising their structural or functional integrity. They have been extensively studied for their potential to transport therapeutics, bioactive molecules, and theragnostic cargoes inside of cells. Since these characteristics make therapeutically important macromolecules less permeable via biological membranes, they are especially desired.

Cell Penetrating Peptide Market- Market Dynamics

Growing demand from pharmaceutical & biotechnology companies drives market growth

As active CPP research and development organizations, pharmaceutical and biotechnology businesses as well as university research institutions are involved in the market. For instance, a better gene editing method created by the University of Pennsylvania's Perelman School of Medicine may fuel the next generation of gene and cell treatments, according to a Penn Medicine paper. The CRISPR gene editing method, which is based on special cell-penetrating peptides, offers potential advantages over current methods for altering biological genomes. Thereby, driving the market growth over the forecast period.

Cell Penetrating Peptide Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.2% over the forecast period (2024-2032)

Based on Type segmentation, Synthetic CPPs were predicted to show maximum market share in the year 2023

Based on application segmentation, Drug Delivery was the leading type in 2023

Based on End-User segmentation, Pharmaceutical and Biotechnology Companies were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Cell Penetrating Peptide Market- Segmentation Analysis:

The Global Cell Penetrating Peptide Market is segmented based on Type, Application, End-User, and Region.

The market is divided into three categories based on Type: Synthetic CPPs, Protein-derived CPPs and Chimeric CPPs. The market is predominantly dominated by synthetic CPPs. Certain synthetic CPPs have been specifically engineered to possess multiple functionalities, enabling the concurrent administration of various payloads or the integration of therapeutic and diagnostic capabilities.

The market is divided into five categories based on application: Drug Delivery, Gene Delivery, Diagnostics, Molecular Imaging and Others. The market is primarily dominated by the Drug Delivery segment. Cell-penetrating peptides (CPPs) have attracted considerable attention in the drug delivery field because of their exceptional capability to enable the intracellular transportation of diverse therapeutic agents.

The market is divided into four categories based on End-user: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Hospitals and Clinics and Others. The market is predominantly controlled by Pharmaceutical and Biotechnology Companies. CPPs are employed in functional genomics research, providing means to manipulate gene expression and investigate cellular functions.

Cell Penetrating Peptide Market- Geographical Insights

Geographically, this market is spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is projected to be dominated by North America, primarily due to the increasing prevalence of diseases such as chronic and infectious diseases. The demand for innovative therapeutic approaches, including CPP-based solutions for drug delivery, is driven by the rising incidence and prevalence of these conditions. Chronic diseases, which are generally incurable and ongoing, affect approximately 133 million Americans, accounting for more than 40% of the country's total population. By 2020, this number is projected to reach an estimated 157 million, with 81 million individuals having multiple conditions, as reported by the National Health Council. Europe holds the second largest region for market growth, mainly due to the rising healthcare expenditure.

Cell Penetrating Peptide Market- Competitive Landscape:

The market for cell penetrating peptides (CPPs) is witnessing significant growth due to the increasing demand in basic research to understand cellular processes and their role as tools for intracellular delivery in studies related to gene therapy, cancer, and neuroscience. The field of nanotechnology, gene editing, and other biotechnologies is also advancing, which may introduce new competitors or complementary technologies in the market. CPPs have garnered considerable attention in various fields, particularly drug delivery, due to their potential for facilitating the intracellular delivery of therapeutic molecules. Therefore, when analyzing the market for cell-penetrating peptides, it is crucial to consider competition analysis and demand in the context of their applications.

Recent Developments:

In July 2023, the U.S. FDA accepted Revance Therapeutics, Inc.'s additional biologic license application for DAXXIFY, which is intended to treat adult cervical dystonia.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELL PENETRATING PEPTIDE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pepscan

Creative Peptides

Cupidpeptides

AltaBioscience Ltd

AnaSpec

Peptomyc

BioAlps

Sarepta Therapeutics, Inc.

REVANCE THERAPEUTICS

PolyPeptide Group

Bachem

Others

GLOBAL CELL PENETRATING PEPTIDE MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Synthetic CPPs
  • Protein-derived CPPs
  • Chimeric CPPs

GLOBAL CELL PENETRATING PEPTIDE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Delivery
  • Gene Delivery
  • Diagnostics
  • Molecular Imaging
  • Others

GLOBAL CELL PENETRATING PEPTIDE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Hospitals and Clinics
  • Others

GLOBAL CELL PENETRATING PEPTIDE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cell Penetrating Peptide Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cell Penetrating Peptide Market Snippet by Type
    • 2.1.2. Cell Penetrating Peptide Market Snippet by Application
    • 2.1.3. Cell Penetrating Peptide Market Snippet by End-User
    • 2.1.4. Cell Penetrating Peptide Market Snippet by Country
    • 2.1.5. Cell Penetrating Peptide Market Snippet by Region
  • 2.2. Competitive Insights

3. Cell Penetrating Peptide Key Market Trends

  • 3.1. Cell Penetrating Peptide Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cell Penetrating Peptide Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cell Penetrating Peptide Market Opportunities
  • 3.4. Cell Penetrating Peptide Market Future Trends

4. Cell Penetrating Peptide Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cell Penetrating Peptide Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cell Penetrating Peptide Market Landscape

  • 6.1. Cell Penetrating Peptide Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cell Penetrating Peptide Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Synthetic CPPs
    • 7.1.3. Protein-derived CPPs
    • 7.1.4. Chimeric CPPs

8. Cell Penetrating Peptide Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Drug Delivery
    • 8.1.3. Gene Delivery
    • 8.1.4. Diagnostics
    • 8.1.5. Molecular Imaging
    • 8.1.6. Others

9. Cell Penetrating Peptide Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Pharmaceutical and Biotechnology Companies
    • 9.1.3. Contract Research Organization (CROs)
    • 9.1.4. Hospitals and Clinics
    • 9.1.5. Others

10. Cell Penetrating Peptide Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cell Penetrating Peptide Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cell Penetrating Peptide Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cell Penetrating Peptide Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Cell Penetrating Peptide Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Cell Penetrating Peptide Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cell Penetrating Peptide Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pepscan
    • 11.2.2. Creative Peptides
    • 11.2.3. Cupidpeptides
    • 11.2.4. AltaBioscience Ltd
    • 11.2.5. AnaSpec
    • 11.2.6. Peptomyc
    • 11.2.7. BioAlps
    • 11.2.8. Sarepta Therapeutics, Inc.
    • 11.2.9. REVANCE THERAPEUTICS
    • 11.2.10. PolyPeptide Group
    • 11.2.11. Bachem
    • 11.2.12. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cell Penetrating Peptide Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Cell Penetrating Peptide Market, by Type 2019-2032 (USD Million)
  • TABLE Cell Penetrating Peptide Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Cell Penetrating Peptide Market, by Application 2019-2032 (USD Million)
  • TABLE Cell Penetrating Peptide Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Cell Penetrating Peptide Market, by End-User 2019-2032 (USD Million)
  • TABLE Cell Penetrating Peptide Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cell Penetrating Peptide Market, by Region 2019-2032 (USD Million)
  • TABLE North America Cell Penetrating Peptide Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Cell Penetrating Peptide Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Cell Penetrating Peptide Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Cell Penetrating Peptide Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Cell Penetrating Peptide Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Cell Penetrating Peptide Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Cell Penetrating Peptide Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Cell Penetrating Peptide Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell Penetrating Peptide Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell Penetrating Peptide Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell Penetrating Peptide Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell Penetrating Peptide Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Cell Penetrating Peptide Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Cell Penetrating Peptide Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Cell Penetrating Peptide Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Cell Penetrating Peptide Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell Penetrating Peptide Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell Penetrating Peptide Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell Penetrating Peptide Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell Penetrating Peptide Market, by End-User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Cell Penetrating Peptide Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Type segment market share analysis, 2023 & 2032
  • FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-User segment market share analysis, 2023 & 2032
  • FIGURE End-User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Cell Penetrating Peptide Market share and leading players, 2023
  • FIGURE Europe Cell Penetrating Peptide Market share and leading players, 2023
  • FIGURE Asia Pacific Cell Penetrating Peptide Market share and leading players, 2023
  • FIGURE Latin America Cell Penetrating Peptide Market share and leading players, 2023
  • FIGURE Middle East and Africa Cell Penetrating Peptide Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Cell Penetrating Peptide Market share analysis by country, 2023
  • FIGURE Germany Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Cell Penetrating Peptide Market share analysis by country, 2023
  • FIGURE India Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Cell Penetrating Peptide Market share analysis by country, 2023
  • FIGURE Brazil Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Cell Penetrating Peptide Market share analysis by country, 2023
  • FIGURE Saudi Arabia Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Cell Penetrating Peptide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)